JOSEPH; Sajan
Patent Applications and Registrations
Patent applications and USPTO patent grants for JOSEPH; Sajan.The latest application filed is for "triple combination of an erk1/2 inhibitor with a braf inhibitor and an egfr inhibitor for use in the treatment of brafv6ooe colorectal cancer".
Company Profile
1.27.26
- JOSEPH; Sajan - Sudbury MA
- JOSEPH; Sajan - Carmel IN
- Joseph; Sajan - Bangalore IN
- Joseph; Sajan - Indianapolis IN
Patent Activity
| Patent | Date |
|---|---|
| TRIPLE COMBINATION OF AN ERK1/2 INHIBITOR WITH A BRAF INHIBITOR AND AN EGFR INHIBITOR FOR USE IN THE TREATMENT OF BRAFv6ooE COLORECTAL CANCER App 20220168250 - BHAGWAT; Shripad Venkatraman ; et al. | 2022-06-02 |
| Salts Of 5,6-dihydro-4h-thieno[2,3-c]pyrrol-4-one Compound As Erk Inhibitors App 20220153750 - COATES; David Andrew ; et al. | 2022-05-19 |
| ERK inhibitors Grant RE48,635 - Cortez , et al. July 13, 2 | 2021-07-13 |
| ERK inhibitors Grant 9,879,029 - Cortez , et al. January 30, 2 | 2018-01-30 |
| Erk Inhibitors App 20170267691 - Cortez; Guillermo S. ; et al. | 2017-09-21 |
| Aminopyridyloxypyrazole compounds Grant 9,617,243 - McMillen , et al. April 11, 2 | 2017-04-11 |
| Erk Inhibitors App 20160375030 - Bhagwat; Shripad Venkatraman ; et al. | 2016-12-29 |
| ERK inhibitors Grant 9,526,733 - Bhagwat , et al. December 27, 2 | 2016-12-27 |
| ERK inhibitors Grant 9,469,652 - Cortez , et al. October 18, 2 | 2016-10-18 |
| Erk Inhibitors App 20160176896 - Cortez; Guillermo S. ; et al. | 2016-06-23 |
| Aminopyridyloxypyrazole Compounds App 20160096823 - MCMILLEN; William T. ; et al. | 2016-04-07 |
| Compounds useful for inhibiting Chk1 Grant 9,067,920 - Joseph , et al. June 30, 2 | 2015-06-30 |
| Compounds Useful for Inhibiting Chk1 App 20130190262 - Joseph; Sajan ; et al. | 2013-07-25 |
| AKT and P70 S6 kinase inhibitors Grant 8,148,387 - Shepherd , et al. April 3, 2 | 2012-04-03 |
| P70 S6 Kinase Inhibitors App 20120071490 - Dally; Robert Dean ; et al. | 2012-03-22 |
| P70 S6 kinase inhibitors Grant 8,093,383 - Joseph January 10, 2 | 2012-01-10 |
| Inhibitors of AKT (protein kinase B) Grant 7,998,977 - Joseph , et al. August 16, 2 | 2011-08-16 |
| Akt And P70 S6 Kinase Inhibitors App 20100120801 - Shepherd; Timothy Alan ; et al. | 2010-05-13 |
| Aromatic ether derivatives useful as thrombin inhibitors Grant 7,700,628 - Argade , et al. April 20, 2 | 2010-04-20 |
| Aromatic Ether Derivatives Useful As Thrombin Inhibitors App 20090227566 - Argade; Ankush Baburao ; et al. | 2009-09-10 |
| Inhibitors Of Akt (protein Kinase B) App 20090221633 - Joseph; Sajan ; et al. | 2009-09-03 |
| P70 S6 Kinase Inhibitors App 20090163714 - Dally; Robert Dean ; et al. | 2009-06-25 |
| Substituted heterocyclic carboxamides with antithrombotic activity Grant 7,449,457 - Herron , et al. November 11, 2 | 2008-11-11 |
| 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (protein kinase B) Grant 7,449,477 - Barda , et al. November 11, 2 | 2008-11-11 |
| Inhibitors of Akt (protein kinase B) Grant 7,414,063 - Al-Awar , et al. August 19, 2 | 2008-08-19 |
| Inhibitors of akt (protein kinase b) App 20070043040 - Al-Awar; Rima Salim ; et al. | 2007-02-22 |
| 7-Phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (proteinkinase b) App 20070037796 - Barda; David Anthony ; et al. | 2007-02-15 |
| Substituted carboxamides Grant 7,163,938 - Herron , et al. January 16, 2 | 2007-01-16 |
| Substituted heterocyclic amides Grant 7,160,878 - Herron , et al. January 9, 2 | 2007-01-09 |
| Aromatic amides Grant 7,129,245 - Beight , et al. October 31, 2 | 2006-10-31 |
| Aromatic amides App 20050282862 - Beight, Douglas Wade ; et al. | 2005-12-22 |
| Agents and methods for the treatment of proliferative diseases Grant 6,867,198 - Al-Awar , et al. March 15, 2 | 2005-03-15 |
| Substituted heterocyclic carboxamides with antithrombotic activity App 20040242581 - Herron, David Kent ; et al. | 2004-12-02 |
| Antithrombotic amides Grant 6,780,878 - Beight , et al. August 24, 2 | 2004-08-24 |
| Aromatic amides Grant 6,759,414 - Beight , et al. July 6, 2 | 2004-07-06 |
| Agents and methods for the treatment of proliferative diseases Grant 6,743,785 - Al-Awar , et al. June 1, 2 | 2004-06-01 |
| Substituted heterocyclic amides App 20040097491 - Herron, David Kent ; et al. | 2004-05-20 |
| Antithrombotic amides Grant 6,716,855 - Beight , et al. April 6, 2 | 2004-04-06 |
| Antithrombotic amides Grant 6,716,839 - Beight , et al. April 6, 2 | 2004-04-06 |
| Substituted carboxamides App 20040058959 - Herron, David Kent ; et al. | 2004-03-25 |
| Antithrombotic amides Grant 6,710,057 - Beight , et al. March 23, 2 | 2004-03-23 |
| Aromatic amides App 20040029874 - Beight, Douglas Wade ; et al. | 2004-02-12 |
| Heteroroaromatic amides as inhibitor of factor Xa Grant 6,689,780 - Beight , et al. February 10, 2 | 2004-02-10 |
| Agents and methods for the treatment of proliferative diseases App 20030229026 - Al-Awar, Rima Salim ; et al. | 2003-12-11 |
| Antithrombotic amides App 20030212069 - Beight, Douglas Wade ; et al. | 2003-11-13 |
| Antithrombotic amides App 20030199504 - Beight, Douglas Wade ; et al. | 2003-10-23 |
| Antithrombotic amides App 20030199505 - Beight, Douglas Wade ; et al. | 2003-10-23 |
| Aromatic amides Grant 6,635,657 - Beight , et al. October 21, 2 | 2003-10-21 |
| Antithrombotic amides App 20030191153 - Beight, Douglas Wade ; et al. | 2003-10-09 |
| Antithrombotic amides Grant 6,610,704 - Beight , et al. August 26, 2 | 2003-08-26 |
| Agents and method for the treatment of proliferative diseases App 20030092676 - Al-Awar, Rima Salim ; et al. | 2003-05-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 